Article by Sharon Rosen
Rapid advances in genomic testing have led to better screening and individualized treatments for many diseases, including rare genetic disorders and cancer. Now that genetic testing is becoming faster and less expensive, should it become part of routine medical care for healthy people? Should everyone have their DNA sequenced to learn the medically informative code that their genome holds? This is one of the questions Keith Stewart, M.B., Ch.B., Carlson and Nelson endowed director, Mayo Clinic Center for Individualized Medicine, will address in his keynote presentation at this year’s Individualizing Medicine Conference. The Center for Individualized Medicine will host the conference on Oct. 9-10, in Rochester, Minnesota.
“The promise – and challenge – of genomic medicine is to apply it so that it will help individualize health care for each patient without creating anxiety or leading to unnecessary ancillary testing. Once we address the barriers to bringing this powerful tool into the hands of every physician, we postulate that we will be able to offer patients better care, based on more individualized information about their health and disease,” says Dr. Stewart.
In his conference presentation, Dr. Stewart will highlight progress to date at Mayo Clinic in advancing individualized medicine and will use his personal journey of having his genome sequenced to highlight the possible benefits (and risks) that preemptive genetic testing could offer patients, including:
Dr. Stewart will also highlight how Mayo Clinic is working to overcome barriers to implementing genetic testing into everyday practice. Mayo researchers and physicians are working to address these questions:
Dr. Stewart is also the Vasek and Anna Maria Polak Professor of Cancer Research and a consultant in the Division of Hematology/Oncology at Mayo Clinic’s campus in Arizona.
This article originally appeared on the Center for Individualized Medicine blog on July 18, 2017.